PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104641
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104641
AI-Powered Imaging Diagnostic Devices Market size was valued at US$ 6.190.8 Million in 2025, expanding at a CAGR of 15.9% from 2026 to 2033.
The AI-powered imaging diagnostic devices market includes all AI solutions-diagnostic hardware, software platforms, services, and algorithms for enhancing medical images to aid image interpretation, detect and diagnose various disease states and conditions, streamline workflows, and assist in diagnostic decisions. It includes AI-powered and diagnostic-enabled devices, which encompass hardware, imaging hardware, and software.
The growing use of imaging-based diagnostics and rising clinical demand for harmonized images and precision health solutions continue to strengthen industry fundamentals and solidify long-term market growth. A total of more than 34,000 physicians and healthcare professionals from over 100 countries worldwide attended the Radiological Society of North America (RSNA) scientific and educational exhibits in 2025. Collectively, all these factors represent imaging diagnostic devices powered by artificial intelligence as a technology that has great importance for driving the upcoming generations of future technologies, characterized by intelligence and precision in medical service provision.
AI-Powered Imaging Diagnostic Devices Market- Market Dynamics
Rising Integration of AI for Early Disease Detection and Clinical Workflow Optimization
AI's proliferation in diagnostic imaging workflows is transforming the clinical environment by addressing increasing examination volumes, backlog reporting, and shortages of imaging specialists. Sophisticated AI models perform automated lesion detection, provide quantitative image analysis, facilitate case prioritization, and enable structured reporting; therefore, they help clinicians achieve faster and more consistent diagnostic outcomes while mitigating inefficient workflows. Health systems are increasingly implementing AI into existing imaging infrastructures to enhance diagnostic confidence while also avoiding impacts on clinical workflows. In 2025, GE HealthCare noted that its AI-embedded imaging technologies assist health systems in over 160 countries in providing optimal patient care, indicating global adoption and belief in AI-embedded technologies in diagnostic imaging, which will likely accelerate technology adoption throughout health systems.
The Global AI-Powered Imaging Diagnostic Devices Market is segmented on the basis of Component, Application, Modality, Technology, End User, and Region.
Among all components, the largest segment is software, as the algorithms driving the systems - be it image recognition and analytic engines, workflow orchestrators, or clinical decision support applications - provide that intelligence. Breakthrough advances in deep learning architectures, multimodal image analysis, cloud-native architectures, and federated learning are transforming precision medicine and offering clinicians enhanced capabilities seamlessly integrated with existing imaging infrastructures. Hardware provides foundational data imaging at superior resolutions and the performance power behind sophisticated AI algorithms. Services -which include installation, validation, cybersecurity, clinician education, and lifecycle maintenance services-continue to grow. In 2025, Siemens Healthineers announced that more than 35 million patients are supported by its connected digital healthcare ecosystem worldwide. The share in this subsegment is expected to remain the highest.
The use of AI in radiology remains the dominant segment of the market, focusing on high-volume imaging like CT, MRI, mammography, X-ray, and ultrasound, where intelligence improves diagnosis and reporting. Breakthrough advances in computer vision applications for image analysis and processing are continuously enhancing applications in the radiography subsegment. Cardiology, in which AI is used for disease characterization, quantitative imaging techniques, and treatment guidance, has shown tremendous growth, whereas treatment planning in oncology with AI is gaining momentum. The use of AI is also expanding in neurology and other specialty subsegments, including orthopedics, obstetrics, and gynecology, due to its proven advantages in improving diagnostic quality and efficiency. The 2025 ECR in Austria received more than 20,500 participants from over 130 nations worldwide, signaling robust development in the field of AI-powered radiology. The share in this subsegment continues to remain the highest.
AI-Powered Imaging Diagnostic Devices Market- Geographical Insights
Healthcare systems in North America continue to lead due to developed healthcare infrastructure, regulations, and the prevalence of digital applications. Healthcare systems have maintained momentum as both the U.S. and Canada drive implementation at academic medical centers, integrated healthcare organizations, and through partnerships between device and technology providers and clinical facilities. Continued FDA approvals for more diagnostic software for imaging use and increased usage in general clinical practices cement the region's position as the best. In 2025, the U.S. FDA already supervised more than 1,000 AI-powered devices, and for a year now, radiology has led this share of authorized devices, all of which also play a regional-dominant role.
Asia-Pacific is emerging as an epicenter for AI-enabled imaging technologies due to increasing health system digitalization trends, global increases in diagnostic imaging volumes, and national policies supporting the use of artificial intelligence in healthcare. The expanded use of these techniques at centers across China, Japan, South Korea, and India has increased their application in large hospitals and centers, as well as within regional diagnostic networks, resulting in improvements in clinical effectiveness. Additionally, regional medical device companies are currently launching AI-enabled imaging systems customized to meet specific needs in the Asia-Pacific region and provide linguistic support for clinicians. The National Health Commission of China is also furthering progress on implementing artificial intelligence across tens of thousands of tertiary hospitals through national smart health schemes as of the beginning of 2025. These factors collectively provide a competitive advantage in regional competition.
Competition in this market is driven by the ability to integrate advanced imaging technologies, sophisticated proprietary AI software, enterprise imaging platforms, cloud-based connectivity, and software for workflow automation. Players differentiate their portfolios by focusing on validated AI algorithms, the ability to develop multimodal AI, clinical validation and approvals of AI, interoperability with hospital information systems, and the integration of clinical decision support into broader digital ecosystem technologies.
As artificial intelligence software matures beyond basic generative techniques, further developments in quantitative imaging algorithms and scalable software platforms will redefine competitive success moving forward. Philips announced in 2025 that its connected health technologies and diagnostic imaging are employed by healthcare providers in more than 100 countries across the globe - indicative of how globalizing digital healthcare is a significant theme within the business world.
In March 2025, GE HealthCare launched its expanded suite of AI-powered applications within GE HealthCare's Edison digital platform; extending advanced, intelligent image analysis, automated clinical workflow orchestration, and integrated clinical decision support capabilities into its CT, MRI, and oncology imaging portfolio.
In May 2025, Siemens Healthineers launched enhancements to its existing AI-Rad Companion's AI automation technologies for its CT and MR imaging portfolio that accelerate reconstruction speed, establish quantitation rigor, and improve the efficiency of any routine diagnostic study.